Skip navigation

Overcome Patient Affordability Barriers in an Evolving Managed Care Landscape

April 24-25, 2018
  • San Francisco, CA

Facilitating patient affordability and access to medication is one of the greatest ongoing areas of concern for pharma/biotech companies. While this is difficult in and of itself, companies must also navigate increased efforts from health plans to limit reimbursement of high cost therapeutics. Challenges continue to arise for manufacturers including formulary exclusions, high deductible plans, changes in benefit design, NDC blocks and step therapy programs.

CBI’s Formulary, Co-Pay and Access Summit provides a forum for industry to convene, benchmark and gain strategies to navigate new and impending access challenges within the value-based landscape while providing valuable patient services and support including coupons, co-pays and bridge programs.

Featured Content Includes:

  • Gain insight on key stakeholder challenges to discover new methods for manufacturers to collaborate with payers, pharmacists and physicians to improve patient outcomes
  • Differentiate physician administered specialty from pharmacy dispensed drugs to pinpoint payer and provider challenges related to documentation, process, patient adherence and compliance
  • Determine the impact of the growing biosimilars market on formulary placement across various care models including hospital, IDN and retail pharmacies
  • Field multiple offers at the same time including PNMT offers, Dollars off, Vouchers and PAP programs
  • Develop best practices to communicate with field reps when there are issues with co-pay cards

Previous Attendee Acclaim:

CBI does a fine job at focusing on relevant and timely market and customer topics. Their staff is professional and accommodating. As a speaker as well as a leader that sends staff to these conferences, I am consistently satisfied and impressed with the discussions and takeaways.

VP, Contracting & Channel Marketing, Bayer

The conference provided the knowledge I was anticipating and looking for. I appreciated the level of different topics that provided solutions to the issues and challenges faced today by manufacturers utilizing co-pay off-set strategies

Vice President, Industry Relations and Managed Markets,
City Drugs Specialty Pharmacy

I’m always so thankful for the perspectives shared at CBI conferences. I always take away great industry knowledge and a deeper understanding of the triumphs and struggles of my industry partners

Access Services Manager, Fairview Specialty Pharmacy

The conference helped me understand the barriers and challenges on the manufacturer and the pharmacy sides

Supervisor Patient Engagement and Customer,
Vanderbilt Specialty Pharmacy Service

I appreciated the patient-focused theme of this conference.

Manager, Contract Administration, Eli Lilly

Agenda was on point.

VP, Strategy, McKesson

Excellent appraisal of approaches and philosophies
in market access and engagement.

Senior Director, Quality Strategic Consumer Group, Janssen

Great conference — so important to keep healthcare landscape and access at the forefront of discussions.

VP, Business Development, PSKW

A cost-effective way to learn from thought leaders, peers and vendors in a topic area of interest. Especially useful at the beginning of the year to set performance goals and think
of new approaches to explore during the year.

Assistant Director, Payer Marketing, Acorda Therapeutics

April 24-25, 2018  San Francisco, CA

CBI’s Formulary, Co-Pay and Access Summit

Overcome Patient Affordability Barriers in an Evolving Managed Care Landscape

Facilitating patient affordability and access to medication is one of the greatest ongoing areas of concern for pharma/biotech companies. While this is difficult in and of itself, companies must also navigate increased efforts from health plans to limit reimbursement of high cost therapeutics. Challenges continue to arise for manufacturers including formulary exclusions, high deductible plans, changes in benefit design, NDC blocks and step therapy programs.

CBI’s Formulary, Co-Pay and Access Summit provides a forum for industry to convene, benchmark and gain strategies to navigate new and impending access challenges within the value-based landscape while providing valuable patient services and support including coupons, co-pays and bridge programs.

Featured Content Includes:

  • Gain insight on key stakeholder challenges to discover new methods for manufacturers to collaborate with payers, pharmacists and physicians to improve patient outcomes
  • Differentiate physician administered specialty from pharmacy dispensed drugs to pinpoint payer and provider challenges related to documentation, process, patient adherence and compliance
  • Determine the impact of the growing biosimilars market on formulary placement across various care models including hospital, IDN and retail pharmacies
  • Field multiple offers at the same time including PNMT offers, Dollars off, Vouchers and PAP programs
  • Develop best practices to communicate with field reps when there are issues with co-pay cards

Previous Attendee Acclaim:

CBI does a fine job at focusing on relevant and timely market and customer topics. Their staff is professional and accommodating. As a speaker as well as a leader that sends staff to these conferences, I am consistently satisfied and impressed with the discussions and takeaways.

VP, Contracting & Channel Marketing, Bayer

The conference provided the knowledge I was anticipating and looking for. I appreciated the level of different topics that provided solutions to the issues and challenges faced today by manufacturers utilizing co-pay off-set strategies

Vice President, Industry Relations and Managed Markets,
City Drugs Specialty Pharmacy

I’m always so thankful for the perspectives shared at CBI conferences. I always take away great industry knowledge and a deeper understanding of the triumphs and struggles of my industry partners

Access Services Manager, Fairview Specialty Pharmacy

The conference helped me understand the barriers and challenges on the manufacturer and the pharmacy sides

Supervisor Patient Engagement and Customer,
Vanderbilt Specialty Pharmacy Service

I appreciated the patient-focused theme of this conference.

Manager, Contract Administration, Eli Lilly

Agenda was on point.

VP, Strategy, McKesson

Excellent appraisal of approaches and philosophies
in market access and engagement.

Senior Director, Quality Strategic Consumer Group, Janssen

Great conference — so important to keep healthcare landscape and access at the forefront of discussions.

VP, Business Development, PSKW

A cost-effective way to learn from thought leaders, peers and vendors in a topic area of interest. Especially useful at the beginning of the year to set performance goals and think
of new approaches to explore during the year.

Assistant Director, Payer Marketing, Acorda Therapeutics

April 24-25, 2018  San Francisco, CA